Article
A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis
24 Jun 2014
Abstract excerpt
BACKGROUND: DNA hypermethylation has emerged as a novel molecular biomarker for the evaluation of prostate cancer diagnosis and prognosis. Defining the specific gene hypermethylation profile for prostate cancer could involve groups of genes that specifically discriminate patients with indolent and aggressive tumors. METHODS: Genome-wide methylation analysis was performed on 83 tumor and 10 normal prostate samples...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
